XOMA Royalty Enters into Agreement to Acquire Generation Bio [Yahoo! Finance]
Generation Bio Co. - Common stock (GBIO)
Company Research
Source: Yahoo! Finance
- Generation Bio's cell-targeted lipid nanoparticles (ctLNP) delivery platform for small interfering RNA (siRNA) and other nucleic acid therapies to be included in XOMA Royalty's portfolio - EMERYVILLE, Calif. and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has entered into an agreement to acquire Generation Bio Co. (“Generation Bio”) (NASDAQ: GBIO) for a cash price of $4.2913 per share at the closing of the merger. Generation Bio stockholders also will receive one non-transferable contingent value right (“CVR”) per share that entitles holders to receive potential payments of a pro rata portion of: 100% of the amount by which net cash at closing, as finally determined pursuant to the CVR agreement, exceeds $29 million; either 90% or 100% of any savings realized by XOMA Royalty on the Company's Cambridge office lease obligations, subject to the timing of resolutio
Show less
Read more
Impact Snapshot
Event Time:
GBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GBIO alerts
High impacting Generation Bio Co. - Common stock news events
Weekly update
A roundup of the hottest topics
GBIO
News
- Shareholder Alert: The Ademi Firm investigates whether Generation Bio Co. is obtaining a Fair Price for its Public ShareholdersPR Newswire
- GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to ShareholdersBusiness Wire
- XOMA Royalty to acquire Generation Bio [Seeking Alpha]Seeking Alpha
- XOMA Royalty Enters into Agreement to Acquire Generation BioGlobeNewswire
- Generation Bio (NASDAQ:GBIO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.MarketBeat
GBIO
Earnings
- 11/5/25 - Beat
GBIO
Analyst Actions
- 11/10/25 - Needham & Company LLC
GBIO
Sec Filings
- 12/15/25 - Form SC14D9C
- 12/15/25 - Form 8-K
- 11/21/25 - Form 4
- GBIO's page on the SEC website